en-clinmed-journal-workflow — independently scanned and version-tracked by SaferSkills.
SaferSkills independently audited en-clinmed-journal-workflow (Agent Skill) and scored it 100/100 (green). The audit ran 55 deterministic rules across Security, Supply Chain, Maintenance, Transparency, and Community; it found 0 high-severity and 0 lower-severity findings. The full rule-by-rule trace and per-finding evidence are below. Free, methodology-open.
Findings & checks · 0 flagged
Every scanned point with the score it earned and what moved between them.
First recorded scan — no prior version to compare against.
The primary manifest — the file an agent reads to learn what this artifact does.
This is the routing skill for the specialty-clinical bundle. It does not replace a single-journal profile; it first classifies the study by specialty, study design, and evidence strength, then routes into the matching per-journal skill for fit and re-framing. It is a sibling to en-natsci-journal-workflow (which holds the general big-four and broad-specialty clinical flagships). These skills are venue-fit aids only — not clinical, diagnostic, or regulatory advice.
pediatrics, psychiatry, surgery, respiratory/critical care, nephrology, endocrinology/diabetes, hepatology/GI, allergy/immunology, rheumatology, stroke, radiology, anesthesiology, obstetrics/gynecology, or urology?
study, diagnostic-accuracy study, systematic review / meta-analysis, guideline / consensus, mechanistic/translational study, or narrative/invited review?
but not definitive result, a hypothesis-generating or exploratory finding, or a synthesis?
flagship), a sub-specialty community, or a general-medicine audience (route up to the big-four in the natural-science bundle)?
| Manuscript signature | Prefer skill |
|---|---|
| General internal-medicine trial / comparative effectiveness | jama-internal-medicine |
| Oncology clinical trial / practice-changing | jama-oncology / annals-of-oncology |
| Authoritative oncology review | nature-reviews-clinical-oncology |
| Cardiology specialty study | jama-cardiology |
| Neurology clinical study | jama-neurology |
| Neuroscience-to-clinical brain disorders, mechanism + clinical | brain |
| Cerebrovascular / stroke | stroke |
| Pediatrics | jama-pediatrics |
| Psychiatry / mental-health (clinical or population) | jama-psychiatry / the-lancet-psychiatry |
| Surgery / perioperative outcomes | jama-surgery |
| Respiratory / pulmonary / critical-care medicine | the-lancet-respiratory-medicine / american-journal-of-respiratory-and-critical-care-medicine |
| Intensive / critical care | critical-care-medicine |
| Diabetes / endocrinology (clinical or population) | the-lancet-diabetes-and-endocrinology / journal-of-clinical-endocrinology-and-metabolism / diabetologia |
| Nephrology / kidney disease | journal-of-the-american-society-of-nephrology / kidney-international |
| Liver disease / hepatology | journal-of-hepatology / hepatology |
| Gastroenterology (clinical) | american-journal-of-gastroenterology |
| Allergy / clinical immunology | journal-of-allergy-and-clinical-immunology |
| Rheumatology / autoimmune | arthritis-and-rheumatology |
| Public-health / population-health intervention | the-lancet-public-health |
| Diagnostic imaging / imaging AI | radiology |
| Anesthesiology / perioperative medicine | anesthesiology |
| Obstetrics / gynecology | american-journal-of-obstetrics-and-gynecology |
| Urology | european-urology |
| Confusable targets | Decision rule |
|---|---|
| A JAMA Network specialty title vs the general big-four (NEJM/JAMA/Lancet/BMJ in the natural-science bundle) | A practice-changing, broadly significant trial may belong at the general venue; a strong specialty-relevant result routes to the JAMA Network / Lancet specialty title. |
jama-oncology vs annals-of-oncology | Route by audience and society fit (JAMA Network vs ESMO) and re-check current scopes; both take high-quality oncology clinical research. |
journal-of-the-american-society-of-nephrology vs kidney-international | Both are top nephrology venues (ASN vs ISN); route by society fit and emphasis and re-check current scopes. |
journal-of-hepatology vs hepatology | EASL vs AASLD flagships; route by society fit and audience and re-check current scopes. |
the-lancet-psychiatry vs jama-psychiatry | Both are top psychiatry venues; route by family fit (Lancet vs JAMA Network) and the framing/audience. |
Specialty journal vs the-lancet-public-health | A population-health/policy intervention routes to public health; a disease-specific clinical result routes to the specialty journal. |
trial registration (number in the manuscript); systematic review → PRISMA; observational → STROBE; diagnostic accuracy → STARD. These are prerequisites, not nice-to-haves, at these venues.
observational study, which outranks a single-center case series; route the design to the venue that expects that level of evidence.
better served by the society specialty flagship than by a general journal that will desk-reject for limited general interest.
invited/commissioned — propose, do not submit unsolicited primary data.
authorship, data sharing) are gating items at every clinical venue.
submitting; never rely on a stale template.
[Top journal skill] <skill-name>
[Alt 1] <skill-name> (reason)
[Alt 2] <skill-name> (reason)
[Do not submit to] <journal> (one-line mismatch reason)
[Study design / reporting guideline] <RCT-CONSORT / cohort-STROBE / review-PRISMA / diagnostic-STARD>
[Biggest current gap] evidence-strength / specialty-fit / registration / reporting-checklist / ethics / official requirements
[Next step] invoke <skill-name> for single-venue fit and re-framing~30 seconds. Free. No account. Every finding cites a rule and a line of evidence.